Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0LA7D | ISIN: CA65337X1042 | Ticker-Symbol:
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEXGENRX INC Chart 1 Jahr
5-Tage-Chart
NEXGENRX INC 5-Tage-Chart

Aktuelle News zur NEXGENRX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.04.NexgenRx reports Q4 results1
06.04.NexgenRx Inc: NexgenRx omits 2023 net P&L in NR, talks revenue1
06.04.NexgenRx Inc.: NexgenRx Announces 2023 Year End Results With Solid Revenue Growth, Continuing Positive EBITDA401TORONTO, ON / ACCESSWIRE / April 5, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the financial year ended December 31, 2023, with continued...
► Artikel lesen
29.12.23NexgenRx Inc.: NexgenRx Announces Director Resignation426TORONTO, ON / ACCESSWIRE / December 29, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") announces the retirement of Dave Bennett from its Board of Directors as he has accepted a senior executive...
► Artikel lesen
21.12.23NexgenRx declares $0.005 dividend2
20.12.23NexgenRx Inc: NexgenRx to pay dividend to common, preferred holders2
20.12.23NexgenRx Inc.: NexgenRX Announces Declaration of Dividend145TORONTO, ON / ACCESSWIRE / December 20, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been declared...
► Artikel lesen
24.11.23Nexgenrx reports Q3 results2
23.11.23NexgenRx Inc: NexgenRx talks EBITDA, omits Q3 P&L from NR1
23.11.23NexgenRx Inc. Announces Q3 2023 Quarterly Results with Continued Revenue Growth and Positive EBITDA344TORONTO, ON / ACCESSWIRE / November 23, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its interim financial results for the third quarter ended September 30, 2023, with continued...
► Artikel lesen
21.08.23NexgenRx Inc.: Nexgenrx Announces Q2 2023 Quarterly Results, Consulting Agreement and Option Grant473TORONTO, ON / ACCESSWIRE / August 21, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its interim financial results for the second quarter ended June 30, 2023, with continued...
► Artikel lesen
16.06.23NexgenRx Inc.: NexgenRx Announces Declaration of Dividend592TORONTO, ON / ACCESSWIRE / June 15, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been declared...
► Artikel lesen
19.05.23NexgenRx Inc.: NexgenRx Announces Q1 2023 Quarterly Results with Continued Revenue Growth and Positive EBITDA and Announces Election of New Director584TORONTO, ON / ACCESSWIRE / May 18, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its interim financial results for the first quarter ended March 31, 2023, with revenues growing...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1